Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 1 May 2008. doi:10.1136/adc.2007.134056
Archives of Disease in Childhood - Fetal and Neonatal Edition 2008;93:F384-F388
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

REVIEWS

Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants

C V Hulzebos1, D E van Imhoff1, A F Bos1, C E Ahlfors2, H J Verkade3, P H Dijk1

1 Department of Pediatrics, Division of Neonatology, University Medical Center Groningen, The Netherlands
2 Vashon, Washington DC, USA
3 Department of Pediatrics, Division of Pediatric Gastroenterology, University Medical Center Groningen, The Netherlands

C V Hulzebos, Department of Pediatrics, Division of Neonatology, University Medical Center Groningen, The Netherlands; c.hulzebos{at}bkk.umcg.nl

Unconjugated hyperbilirubinaemia occurs in almost all premature infants and is potentially neurotoxic. Treatment is based on total serum bilirubin (TSB), but treatment thresholds are not evidence based. Free bilirubin (Bf)—that is, not bound to albumin, seems a better parameter for bilirubin neurotoxicity, but measurements of Bf are not available in clinical practice. The bilirubin/albumin (B/A) ratio is considered a surrogate parameter for Bf and an interesting additional parameter in the management of hyperbilirubinaemia. This paper reviewed the evidence supporting the use of B/A ratios for predicting bilirubin-induced neurological dysfunction (BIND) including neurodevelopmental delay in jaundiced premature infants (gestational age less than 32 weeks). A literature search was performed and six publications reviewed regarding B/A ratios in the management and outcome of jaundiced premature infants. No prospective clinical trials had been undertaken to show whether bilirubin-induced neurotoxicity is reduced or whether unnecessary treatment is avoided by using the B/A ratio in addition to TSB. Recently, a randomised controlled trial evaluating the effect of the additional use of the B/A ratio on neurodevelopmental outcome in jaundiced premature infants has been initiated. Based on the prevailing evidence many authorities suggest that the additional use of the B/A ratio may be valuable when evaluating jaundiced premature infants.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Okumura, A., Kidokoro, H., Shoji, H., Nakazawa, T., Mimaki, M., Fujii, K., Oba, H., Shimizu, T. (2009). Kernicterus in Preterm Infants. Pediatrics 123: e1052-e1058 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs